Skip to main content
. Author manuscript; available in PMC: 2010 Dec 18.
Published in final edited form as: Transplantation. 1995 Jul 27;60(2):158–171. doi: 10.1097/00007890-199507000-00009

Table 5.

MLR against BN (syngeneic), LEW (donor), and ACI (third-party) in naive and bone marrow–, whole blood–, or thymocyte-primed BN ratsa

BN responderb Stimulator
BN (syngeneic) LEW (donor) ACI (third-party)
Naive 235±78 36.558±1844 26.979±6276
Bone marrow 703±184 21.122±5176 24.450±12.367
Blood 965±449 30.983±5215 36.020±7877
Thymus 911±55 15.651±4454 17.842±4181
a

All values are mean ± SD (cpm) of triplicate wells.

b

BN animals received bone marrow, thmocytes (250× l06) or 3 ml whole blood from LEW (day 0) and were treated with tacrolimus (1.0 mg/kg/day on days 0 to 13 and 20, and 27). Cervical lymph nodes were obtained on day 100 for analysis.